These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25732991)

  • 1. Buprenorphine ingestion in a 23-month-old boy.
    Swartzentruber GS; Richardson WH; Mack EH
    Hosp Pediatr; 2015 Mar; 5(3):164-6. PubMed ID: 25732991
    [No Abstract]   [Full Text] [Related]  

  • 2. Editor's Highlight: Neurorespiratory Effects of Buprenorphine and Ethanol in Combination: A Mechanistic Study of Drug-Drug Interactions in the Rat.
    Cohier C; Chevillard L; Salle S; Risède P; Roussel O; Mégarbane B
    Toxicol Sci; 2017 Feb; 155(2):389-399. PubMed ID: 27803387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine may not be as safe as you think: a pediatric fatality from unintentional exposure.
    Kim HK; Smiddy M; Hoffman RS; Nelson LS
    Pediatrics; 2012 Dec; 130(6):e1700-3. PubMed ID: 23129079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone.
    Sekar V; Tomaka F; Lefebvre E; De Pauw M; Vangeneugden T; van den Brink W; Hoetelmans R
    J Clin Pharmacol; 2011 Feb; 51(2):271-8. PubMed ID: 20421512
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers.
    Yassen A; Olofsen E; van Dorp E; Sarton E; Teppema L; Danhof M; Dahan A
    Clin Pharmacokinet; 2007; 46(11):965-80. PubMed ID: 17922561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone pro-drug rescues morphine induced respiratory depression in Sprague-Dawley rats.
    Wallisch M; El Rody NM; Huang B; Koop DR; Baker JR; Olsen GD
    Respir Physiol Neurobiol; 2012 Jan; 180(1):52-60. PubMed ID: 22027217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine implants (Probuphine) for opioid dependence.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):94-5. PubMed ID: 27403784
    [No Abstract]   [Full Text] [Related]  

  • 8. Respiratory effects of buprenorphine/naloxone alone and in combination with diazepam in naive and tolerant rats.
    Cohier C; Chevillard L; Risède P; Roussel O; Mégarbane B
    Toxicol Lett; 2014 Jul; 228(2):75-84. PubMed ID: 24769261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects in children after unintentional buprenorphine exposure.
    Geib AJ; Babu K; Ewald MB; Boyer EW
    Pediatrics; 2006 Oct; 118(4):1746-51. PubMed ID: 17015570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The possible consequences of combining Lorazepam and buprenorphine/naloxone: a case review.
    Martin HA
    J Emerg Nurs; 2011 Mar; 37(2):200-2. PubMed ID: 21397143
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
    Stimolo C; Favero VD; Zecchinato G; Buson R; Cusin D; Pellachin P; Simonetto P
    Clin Drug Investig; 2010; 30 Suppl 1():27-31. PubMed ID: 20450243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interactions between buprenorphine/naloxone and raltegravir in subjects receiving chronic buprenorphine/naloxone treatment.
    Douglas Bruce R; Moody DE; Chodkowski D; Andrews L; Fang WB; Morrison J; Parsons TL; Friedland GH
    Am J Drug Alcohol Abuse; 2013 Mar; 39(2):80-5. PubMed ID: 23421567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials.
    Ciraulo DA; Hitzemann RJ; Somoza E; Knapp CM; Rotrosen J; Sarid-Segal O; Ciraulo AM; Greenblatt DJ; Chiang CN
    J Clin Pharmacol; 2006 Feb; 46(2):179-92. PubMed ID: 16432270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
    Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous Buprenorphine: A Substitute for Naloxone in Methadone-Overdosed Patients?
    Zamani N; Hassanian-Moghaddam H
    Ann Emerg Med; 2017 Jun; 69(6):737-739. PubMed ID: 28237362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in murine respiratory dynamics induced by aerosolized carfentanil inhalation: Efficacy of naloxone and naltrexone.
    Tuet WY; Pierce SA; Racine MC; Tressler J; McCranor BJ; Sciuto AM; Wong B
    Toxicol Lett; 2019 Nov; 316():127-135. PubMed ID: 31539569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
    Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
    Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-induced respiratory effects: new data on buprenorphine.
    Dahan A
    Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability investigation of a new tilidine/naloxone liquid formulation compared to a reference formulation.
    Martin W; Ring J; Gaupp M; Arnold P; Sennewald R; Doser K
    Arzneimittelforschung; 1999 Jul; 49(7):599-607. PubMed ID: 10442208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic switch to buprenorphine/naloxone from buprenorphine alone: clinical experience in an Italian addiction centre.
    Montesano F; Zaccone D; Battaglia E; Genco F; Mellace V
    Clin Drug Investig; 2010; 30 Suppl 1():13-9. PubMed ID: 20450241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.